medical glp 1 coverage Designing fiscally viable of GLP-1 weight-loss drugs Medical Coding GLP-1 Medications |

2025;8(1):e2457232-e

GLP-1 medications like semaglutide and tirzepatide have transformed weight loss treatment

Demand for GLP-1 Companion Products in the global market is expected to grow at a CAGR of 10.7% between 2026 and 2036

We verified that food consumption did not differ significantly between the Baseline and the Vehicle control conditions, with no significant temporal trends in either (see Control analyses of Vehicle and Baseline data section of the Supplementary Results)

The 5As Framework (assess, advise, agree, assist, and arrange) is useful to guide the patient-clinician interaction to create foundation for long-term adherence to behavior change

This delayed gastric emptying may theoretically alter the absorption rate of oral medications, including paracetamol, though this is not typically clinically significant for paracetamol specifically